# Biozen

> Biozen builds an ultra-compact, cuffless blood pressure sensor that combines optical (PPG) and pressure-fusion technology to produce a clinically accurate measurement in seconds — without an inflatable cuff and without per-user calibration. The flagship product, the BP1000, received FDA 510(k) clearance in May 2026 (K253152). The sensor is engineered for integration into wearables, consumer health products, and medical devices.

> Tagline: "Cuffless · Compact · Discreet"

## About

Biozen, LLC is a privately held digital health company headquartered in Oklahoma City, Oklahoma, with research and development in Atlanta, Georgia. The company develops sensor-fusion technology for cardiovascular monitoring. Its flagship product — the BP1000 — is a cuffless blood pressure monitor that pairs with a companion mobile app to deliver real spot measurements (not estimates) from the fingertip. Biozen has built a global IP portfolio around the technology with 96 patents granted or filed (68 issued, 28 pending).

## Leadership

- Dikran Tourian — Chief Executive Officer
- Omer Inan, PhD — Chief Scientific Officer; academic background in cardiovascular sensing
- Shaun Dubuque — Chief Technology Officer
- Kenneth Civello, MD — Advisor (cardiology, electrophysiology)

## Regulatory status

- FDA 510(k) Cleared — K253152 (May 11, 2026)
- Validated against ISO 81060-2:2018 (international standard for non-invasive blood pressure devices)
- Indications for use: spot check measurement of blood pressure in adults ages 22–59 (excluding active arrhythmias, peripheral artery disease, or pregnancy); environment of use: home.

## Product features

- **Clinically Validated Accuracy** — performance benchmarked against reference cuff methods under ISO 81060-2:2018.
- **No Cuff Required** — measurement happens through fingertip contact at a single small sensor; no inflatable arm cuff, tubing, or pump.
- **Fits in Your Pocket** — handheld, pocketable form factor.
- **Long battery life** — rechargeable; multi-day battery on a single charge.
- **Companion Mobile App** — results, history, and provider-facing readouts surface in the Biozen app.
- **Results in Seconds** — single-touch measurement; no warm-up, no calibration step.

## How the technology works

The BP1000 uses the same proven measurement science as an automated cuff — applied through the fingertip rather than an inflatable arm cuff. The user gently presses down on the device's sensors while following a visual target in the companion app, gradually applying the pressure needed to achieve arterial occlusion. The device pairs proprietary pressure sensing with photoplethysmography (PPG) — an optical technique that detects changes in blood volume — to precisely identify when occlusion occurs, then computes blood pressure through physiologically informed algorithms. Because the device measures the underlying physiology directly rather than estimating it from indirect signals, it requires no per-user calibration against a cuff.

## Patent footprint — "One of a kind, worldwide."

Biozen has 96 patents granted or filed (68 issued, 28 pending) across:

- **North & South America** — 18 issued (US 8, Brazil 4, Canada 3, Mexico 3), 11 pending (US)
- **Europe** — 21 issued (EPO 17 incl. 3 Unitary Patents covering 18 EU member states; Russia 4), 6 pending (EPO)
- **Asia** — 21 issued (China 5, India 4, Singapore 4, Japan 3, Korea 3, Hong Kong 2), 8 pending (China 6, India 2)
- **Australia** — 8 issued
- **Patent Cooperation Treaty** — 3 pending

The IP portfolio covers sensor design, signal processing, fusion algorithms, and form-factor variants for integration partners.

## Engineered for integration — partnership focus areas

Biozen's sensing platform is designed to be embedded into partner products. Active partnership categories:

- Wearable brands (smartwatches, fitness bands, recovery devices, hearables)
- Consumer health brands (smart sleep, recovery, aging-in-place products, smart-home health)
- Medical device manufacturers (patient monitors, connected BP cuffs, hospital instruments)
- Healthcare providers and clinicians (clinical evaluation, deployment partners)
- Researchers (academic and clinical study collaborations)
- Investors
- Press / media

Inquiries: visit the partnership section on the site to submit details, or contact info@biozen.com directly.

## Site map

- [Home](https://biozen.com/): single-page marketing site covering the device, the cuffless-fingertip technology demo, the product feature checklist, the global patent footprint, the integration-partnership form, and contact details.
- [Press release](https://biozen.com/media): FDA 510(k) clearance announcement.
- [LinkedIn](https://www.linkedin.com/company/biozen-llc)

## Contact

- Press inquiries: press@biozen.com
- General inquiries: info@biozen.com